Coronavirus News and Research

RSS

COVID-19 rapid antibody test receives CE mark and mass production begins

The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.

31 Jul 2020

Leading expert is sounding the alarm on newly-identified symptom of coronavirus

A VascularNurse Consultant and senior lecturer at the University of Huddersfield is sounding the alarm on a newly-identified symptom of the coronavirus, dubbed COVID-toes, after witnessing a sharp increase in the amount of patients being referred to vascular clinics, with similar symptoms to arterial disease but, who then test positive for COVID-19.

31 Jul 2020

Don’t count on lower premiums despite pandemic-driven boon for insurers

When COVID-19 smacked the United States in March and April, health plans feared medical costs could skyrocket, jacking up premiums drastically in 2021, when millions of the newly unemployed might still be out of work.

31 Jul 2020

Avoiding care during the pandemic could mean life or death

These days, Los Angeles acting teacher Deryn Warren balances her pain with her fear. She's a bladder cancer patient who broke her wrist in November. She still needs physical therapy for her wrist, and she's months late for a cancer follow-up.

31 Jul 2020

Managing cancer patients during COVID-19 pandemic

An ESMO interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published today in Annals of Oncology.

31 Jul 2020

War of sugars - estrogen provides protection in COVID-19

Now a new study published on the preprint server bioRxiv in July 2020 reports that sex hormones could affect the function of the fusion protein that is dependent upon the human ACE2 receptor, thus preventing the entry of the virus into the host cell.

31 Jul 2020

Researchers report a liquid biopsy for COVID-19

A new study published on the preprint server medRxiv in July 2020 reports the potential of cell-free DNA as a marker of the severity of disease in COVID-19. This could help triage patients as well as provide a prognostic marker.

30 Jul 2020

Researcher uses in silico analysis of SARS-CoV-2 spike protein to fast-track passive immunity

With millions of COVID-19 cases reported across the globe, people are turning to antibody tests to find out whether they have been exposed to the coronavirus that causes the disease. But what are antibodies? Why are they important? If we have them, are we immune to COVID-19? And if not, why not?

30 Jul 2020

CZI, CZ Biohub, and The State Of California join forces to track COVID-19 transmission

Today, the Chan Zuckerberg Biohub, in partnership with the Chan Zuckerberg Initiative, announced that it will provide free whole genome sequencing and analysis of the SARS-CoV-2 virus to all California Departments of Public Health and California local health jurisdictions through a newly-launched effort called the California COVID Tracker.

30 Jul 2020

From swab to sequencing - scalable method for identifying SARS-CoV-2

A research group headed by Stanford University scientists has developed a scalable, high throughput method to generate high fidelity whole genome and HLA sequencing, viral genomes, and representation of human transcriptome from single nasopharyngeal swabs of coronavirus disease (COVID19) patients. Their results are published on the medRxiv preprint server.

30 Jul 2020

Caution needed in reopening of U.S. primary schools during COVID-19

Researchers in Italy have reported on the success of the contact tracing efforts made to control the coronavirus disease 2019 (COVID-19) outbreak in the province of Trento during phase I (March to April) of the epidemic.

30 Jul 2020

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

The development of a safe and effective vaccine will likely be required to end the COVID-19 pandemic. A group of scientists, led by Beth Israel Deaconess Medical Center immunologist Dan H. Barouch, MD, PhD, now report that a leading candidate COVID-19 vaccine developed at BIDMC in collaboration with Johnson & Johnson raised neutralizing antibodies and robustly protected non-human primates against SARS-CoV-2, the virus that causes COVID-19.

30 Jul 2020

Smoking worsens COVID-19 severity, warn researchers

A study conducted by researchers at the University of California, Los Angeles, suggests that smoking increases the risk of more severe lung disease in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

30 Jul 2020

KHN’s ‘What the Health?’: Republicans in COVID disarray

President Donald Trump's pivot to a more serious view of the coronavirus pandemic didn't last long. This week, he was again touting hydroxychloroquine, an antimalarial drug that has not been shown to work against the virus.

30 Jul 2020

Medi-Cal agency’s new head wants to tackle disparities and racism

When Will Lightbourne looked at the statistics behind California's coronavirus cases, the disparities were "blindingly clear": Blacks and Latinos are dying at higher rates than most other Californians.

30 Jul 2020

New test rapidly determines neutralizing antibodies against Sars-Cov-2

To determine immunity to Sars-Cov-2 and the effectiveness of potential vaccines, the amount of neutralizing antibodies in the blood of recovered or vaccinated individuals must be determined.

30 Jul 2020

Namaste noir: Yoga co-op seeks to diversify yoga to heal racialized trauma

Beverly Grant spent years juggling many roles before yoga helped her restore her balance.

30 Jul 2020

Missourians to vote on Medicaid expansion as crisis leaves millions without insurance

Haley Organ thought she had everything figured out. After graduating from a small private college just outside Boston, she earned her master's degree, entered the workforce and eventually landed a corporate job here as a data analyst.

30 Jul 2020

New program to reverse the effects of Type 2 diabetes and beat COVID-19

The Diabetes Reversal Company has developed a pioneering programme based on weight loss, lifestyle change and one-to-one clinical support to reduce and reverse the effects of Type 2 diabetes, helping deliver the goals in the Government’s newly published National Obesity Strategy.

30 Jul 2020

Urgent care providers are driven to deliver outstanding, integrated clinical care

Round the clock primary and community care has rarely been in the spotlight in terms of the role it plays in the wider healthcare landscape.

30 Jul 2020

Coronavirus News and Research

COVID-19 rapid antibody test receives CE mark and mass production begins

Leading expert is sounding the alarm on newly-identified symptom of coronavirus

Don’t count on lower premiums despite pandemic-driven boon for insurers

Avoiding care during the pandemic could mean life or death

Managing cancer patients during COVID-19 pandemic

War of sugars - estrogen provides protection in COVID-19

Researchers report a liquid biopsy for COVID-19

Researcher uses in silico analysis of SARS-CoV-2 spike protein to fast-track passive immunity

CZI, CZ Biohub, and The State Of California join forces to track COVID-19 transmission

From swab to sequencing - scalable method for identifying SARS-CoV-2

Caution needed in reopening of U.S. primary schools during COVID-19

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

Smoking worsens COVID-19 severity, warn researchers

KHN’s ‘What the Health?’: Republicans in COVID disarray

Medi-Cal agency’s new head wants to tackle disparities and racism

New test rapidly determines neutralizing antibodies against Sars-Cov-2

Namaste noir: Yoga co-op seeks to diversify yoga to heal racialized trauma

Missourians to vote on Medicaid expansion as crisis leaves millions without insurance

New program to reverse the effects of Type 2 diabetes and beat COVID-19

Urgent care providers are driven to deliver outstanding, integrated clinical care

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News